Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis.

Martyré MC, Romquin N, Le Bousse-Kerdiles MC, Chevillard S, Benyahia B, Dupriez B, Demory JL, Bauters F.

Br J Haematol. 1994 Sep;88(1):9-16.

PMID:
7803262
2.
3.

Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.

Wang JC, Chang TH, Goldberg A, Novetsky AD, Lichter S, Lipton J.

Exp Hematol. 2006 Dec;34(12):1617-23.

PMID:
17157157
4.

Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis.

Martyré MC, Le Bousse-Kerdiles MC, Romquin N, Chevillard S, Praloran V, Demory JL, Dupriez B.

Br J Haematol. 1997 May;97(2):441-8.

PMID:
9163611
5.

Deposition of transforming growth factor-beta in the marrow in myelofibrosis, and the intracellular localization and secretion of TGF-beta by leukemic cells.

Johnston JB, Dalal BI, Israels SJ, Oh S, McMillan E, Begleiter A, Michaud G, Israels LG, Greenberg AH.

Am J Clin Pathol. 1995 May;103(5):574-82.

PMID:
7741102
6.

[TGF-beta and platelet].

Kogawa K, Mogi Y, Morii K, Takimoto R, Niitsu Y.

Rinsho Ketsueki. 1994 Apr;35(4):370-5. Japanese.

PMID:
8028182
7.

Involvement of the fibrogenic cytokines, TGF-beta and bFGF, in the pathogenesis of idiopathic myelofibrosis.

Le Bousse-Kerdilès MC, Martyré MC; French INSERM research network on Idiopathic Myelofibrosis..

Pathol Biol (Paris). 2001 Mar;49(2):153-7. Review.

PMID:
11317961
8.

Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia.

Le Bousse-Kerdilès MC, Chevillard S, Charpentier A, Romquin N, Clay D, Smadja-Joffe F, Praloran V, Dupriez B, Demory JL, Jasmin C, Martyré MC.

Blood. 1996 Dec 15;88(12):4534-46.

9.

Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis.

Schmitt A, Jouault H, Guichard J, Wendling F, Drouin A, Cramer EM.

Blood. 2000 Aug 15;96(4):1342-7.

10.

Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia.

Martyré MC, Magdelenat H, Bryckaert MC, Laine-Bidron C, Calvo F.

Br J Haematol. 1991 Jan;77(1):80-6.

PMID:
1998600
11.

Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L.

Taksin AL, Couedic JP, Dusanter-Fourt I, Massé A, Giraudier S, Katz A, Wendling F, Vainchenker W, Casadevall N, Debili N.

Blood. 1999 Jan 1;93(1):125-39.

12.

Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors.

Giraudier S, Chagraoui H, Komura E, Barnache S, Blanchet B, LeCouedic JP, Smith DF, Larbret F, Taksin AL, Moreau-Gachelin F, Casadevall N, Tulliez M, Hulin A, Debili N, Vainchenker W.

Blood. 2002 Oct 15;100(8):2932-40.

13.
14.

Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis.

Akiyama T, Matsunaga T, Terui T, Miyanishi K, Tanaka I, Sato T, Kuroda H, Takimoto R, Takayama T, Kato J, Yamauchi N, Kogawa K, Sakamaki S, Hirayama Y, Kohda K, Niitsu Y.

Leukemia. 2005 Sep;19(9):1558-66.

PMID:
16034467
15.

Systemic transforming growth factor-beta in patients with bone marrow fibrosis--pathophysiological implications.

Rameshwar P, Chang VT, Thacker UF, Gascón P.

Am J Hematol. 1998 Oct;59(2):133-42.

16.
17.
18.

TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.

Shehata M, Schwarzmeier JD, Hilgarth M, Hubmann R, Duechler M, Gisslinger H.

J Clin Invest. 2004 Mar;113(5):676-85.

19.

Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis.

Sakaguchi K, Kitano M, Nishimura M, Senoh T, Ohta T, Terao M, Shinji N, Koide N, Tsuji T.

Hepatogastroenterology. 2004 Nov-Dec;51(60):1780-3.

PMID:
15532825

Supplemental Content

Support Center